Concord Medical (CCM) - מכירות החברה

Narrow specialization and expensive equipment allow Concord Medical Services (CCM) to control the cost of oncology services within its regions. The company's execution history clearly demonstrates this resilience, with the indicator currently at 0.06. The fundamentals rely on strict government licenses and the cost of "cyberknives," which create barriers for competitors, although long payback periods and debt create financial pressure.

The market values Concord Medical Services (CCM) as a stable asset with a steady cash flow. This metric captures the total daily revenue, reflecting the business's real liquidity and fundamental resilience. By analyzing the company's sales trend, an investor can see the efficiency of oncology center management despite external dependence on equipment suppliers. This indicator classifies the security as a defensive asset with predictable income.